The company’s AI-powered assistant, integrated across its productivity suite, experienced a significant outage today (Dec. 9), affecting large numbers of users across the UK. Reports of disruptions ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or ...
Learn a methodical way of reclaiming your attention and maximizing your output with AI. By exploring three critical variables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback